Variant report
Variant | nsv963885 |
---|---|
Chromosome Location | chr2:141918827-141927844 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr2:141920037-141920078 | LNCaP | prostate: | n/a | n/a |
2 | E2F4 | chr2:141927622-141927725 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FAM48A | chr2:141923135-141923254 | GM12878 | blood: | n/a | n/a |
4 | FOS | chr2:141919987-141920210 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr2:141919972-141920222 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr2:141919888-141920298 | Hela-S3 | cervix: | n/a | n/a |
7 | FOSL2 | chr2:141919862-141920357 | MCF-7 | breast: | n/a | n/a |
8 | GATA3 | chr2:141919904-141920251 | MCF-7 | breast: | n/a | n/a |
9 | JUND | chr2:141920102-141920154 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | JUND | chr2:141919972-141920186 | HepG2 | liver: | n/a | chr2:141920079-141920090 |
11 | JUND | chr2:141919883-141920271 | Hela-S3 | cervix: | n/a | chr2:141920079-141920090 |
12 | NR2F2 | chr2:141919933-141920329 | MCF-7 | breast: | n/a | n/a |
13 | POLR2A | chr2:141923862-141924029 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | STAT3 | chr2:141926602-141926749 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:141913575..141915703-chr2:141918987..141921104,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-904P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34332358 | chr2:141919819-141919820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs13428151 | chr2:141919828-141919829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547770954 | chr2:141919836-141919837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567708297 | chr2:141919870-141919871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544203073 | chr2:141919871-141919872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs536635374 | chr2:141919901-141919902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550330103 | chr2:141919921-141919922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs140363562 | chr2:141919923-141919924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2222233 | chr2:141919943-141919944 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs558432341 | chr2:141919965-141919966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188216386 | chr2:141919979-141919980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534568300 | chr2:141920048-141920049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554846744 | chr2:141920051-141920052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116486875 | chr2:141920058-141920059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542999312 | chr2:141920075-141920076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570579222 | chr2:141920081-141920082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556668207 | chr2:141920116-141920117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2203809 | chr2:141920136-141920137 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs180971072 | chr2:141920159-141920160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565298276 | chr2:141920160-141920161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs149965529 | chr2:141920176-141920177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546958755 | chr2:141920184-141920185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs541399383 | chr2:141920186-141920187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561546115 | chr2:141920197-141920198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs16845527 | chr2:141920218-141920219 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs550170958 | chr2:141920223-141920224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186386064 | chr2:141920246-141920247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553108288 | chr2:141920331-141920332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144990517 | chr2:141920350-141920351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs141063066 | chr2:141920466-141920467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534806930 | chr2:141920469-141920470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs145050752 | chr2:141920581-141920582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189656722 | chr2:141920582-141920583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs145192614 | chr2:141926603-141926604 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs558804233 | chr2:141926622-141926623 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs79700219 | chr2:141926705-141926706 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs560118537 | chr2:141927416-141927417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs538196387 | chr2:141927437-141927438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs183079868 | chr2:141927441-141927442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187734012 | chr2:141927503-141927504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs193103522 | chr2:141927537-141927538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1249456 | chr2:141927544-141927545 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs16845549 | chr2:141927561-141927562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs554104270 | chr2:141927679-141927680 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs377494325 | chr2:141927684-141927685 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs556382865 | chr2:141927686-141927687 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs147078848 | chr2:141927695-141927696 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs557012206 | chr2:141927730-141927731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs576596840 | chr2:141927786-141927787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs189143203 | chr2:141927787-141927788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Cancer | 20164920 | CNVD |
Hypertension | 22686481 | CNVD |
Hypospadia | 22686481 | CNVD |
Intellectual disability | 22686481 | CNVD |
Omphalocele | 22686481 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 22341455 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:141919800-141920600 | Enhancers | Hela-S3 | cervix |
2 | chr2:141920000-141920600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr2:141927400-141927800 | Enhancers | Dnd41 | blood |